GoalVest Advisory’s Dentsply Sirona XRAY Stock Holding History

GoalVest Advisory’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2	Closed	–	–	552
2022 Q1	$0	Buy	+2	New	+$106	﹤0.01%	513

Other funds holding XRAY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GoalVest Advisory's XRAY Position: Q2 2022 in Review

GoalVest Advisory sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 2 shares.

GoalVest Advisory first reported a position in XRAY in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 470 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.

GoalVest Advisory reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
GoalVest Advisory sold 2 Dentsply Sirona shares in Q2 2022.
GoalVest Advisory first reported a position in Dentsply Sirona in Q1 2022 and held it in 1 quarter.
GoalVest Advisory's Dentsply Sirona position peaked at $0 in Q1 2022.
470 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.

Based on GoalVest Advisory's 13F filing for Q2 2022, filed 6 Jul 2022.